⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LGND News
Ligand Pharmaceuticals Inc.
Ligand Reports Second Quarter 2026 Financial Results
globenewswire.com
LGND
Ligand Reports Second Quarter 2026 Financial Results
globenewswire.com
LGND
Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
globenewswire.com
LGND
Form 8-K
sec.gov
LGND
LGNDZ
LGNZZ
LGNXZ
LGNYZ
Form 8-K
sec.gov
XOMAP
XOMAO
XOMA
LGND
XOMA Royalty Announces Closing of Its Acquisition by Ligand
globenewswire.com
LGND
Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
globenewswire.com
LGND
Form 8-K
sec.gov
LGNXZ
LGNYZ
LGND
LGNDZ
LGNZZ
Ligand Announces Closing of Convertible Senior Notes Offering
globenewswire.com
LGND
Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering
globenewswire.com
LGND